Mylan asks US court to clear Wegovy generic from Novo patent claims

By Blake BrittainGeneric drugmaker Viatris NASDAQ:VTRS has sued Danish pharmaceutical giant Novo Nordisk OMXCOP:NOVO_B in Delaware federal court, seeking a ruling that its proposed generic of Novo's blockbuster GLP-1 drug Wegovy would not violate Novo's patent rights.The case is Mylan Pharmaceutica…